Apolipoprotein E genotype moderates the association between dietary polyunsaturated fat and brain function: an exploration of cerebral glutamate and cognitive performance

References

• Laitinen MH, Ngandu T, Rovio S, Helkala E-L, Uusitalo U, Viitanen M, et al. Fat intake at midlife and risk of dementia and Alzheimer’s disease: a population-based study. Dement Geriatr Cogn Disord 2006;22(1):99–107.
   PubMed Web of Science ®Google Scholar
• Vercambre M-N, Grodstein F, Kang JH. Dietary fat intake in relation to cognitive change in high-risk women with cardiovascular disease or vascular factors. Eur J Clin Nutr 2010;64(10):1134–40.
   PubMed Web of Science ®Google Scholar
• Fontani G, Corradeschi F, Felici A, Alfatti F, Migliorini S, Lodi L. Cognitive and physiological effects of omega-3 polyunsaturated fatty acid supplementation in healthy subjects. Eur J Clin Investig 2005;35(11):691–9.
   PubMed Web of Science ®Google Scholar
• Berti V, Murray J, Davies M, Spector N, Tsui WH, Li Y, et al. Nutrient patterns and brain biomarkers of Alzheimer’s disease in cognitively normal individuals. J Nutr Health Aging 2015;19(4):413–23.
   PubMed Web of Science ®Google Scholar
• Cunnane SC, Plourde M, Pifferi F, Bégin M, Féart C, Barberger-Gateau P. Fish, docosahexaenoic acid and Alzheimer's disease. Prog Lipid Res 2009;48(5):239–56.
   PubMed Web of Science ®Google Scholar
• Belkouch M, Hachem M, Elgot A, Lo Van A, Picq M, Guichardant M, et al. The pleiotropic effects of omega-3 docosahexaenoic acid on the hallmarks of Alzheimer's disease. J Nutr Biochem 2016;38(Supplement C):1–11.
   PubMedGoogle Scholar
• Latour A, Grintal B, Champeil-Potokar G, Hennebelle M, Lavialle M, Dutar P, et al. Omega-3 fatty acids deficiency aggravates glutamatergic synapse and astroglial aging in the rat hippocampal CA1. Aging Cell 2013;12(1):76–84.
   PubMed Web of Science ®Google Scholar
• Oleson S, Gonzales MM, Tarumi T, Davis JN, Cassill CK, Tanaka H, et al. Nutrient intake and cerebral metabolism in healthy middle-aged adults: implications for cognitive aging. Nutr Neurosci 2017;20(8):489–96.
   PubMed Web of Science ®Google Scholar
• Sheldon AL, Robinson MB. The role of glutamate transporters in neurodegenerative diseases and potential opportunities for intervention. Neurochem Int 2007;51(6–7):333–55.
   PubMed Web of Science ®Google Scholar
• Potier B, Billard J-M, Rivière S, Sinet P-M, Denis I, Champeil-Potokar G, et al. Reduction in glutamate uptake is associated with extrasynaptic NMDA and metabotropic glutamate receptor activation at the hippocampal CA1 synapse of aged rats. Aging Cell 2010;9(5):722–35.
   PubMed Web of Science ®Google Scholar
• Barberger-Gateau P, Raffaitin C, Letenneur L, Berr C, Tzourio C, Dartigues JF, et al. Dietary patterns and risk of dementia: the three-city cohort study. 2007(1526-632X (Electronic)).
   Google Scholar
• Huang TL, Zandi PP, Tucker KL, Fitzpatrick AL, Kuller LH, Fried LP, et al. Benefits of fatty fish on dementia risk are stronger for those without APOE epsilon4. 2005(1526-632X (Electronic)).
   Google Scholar
• Quinn JF, Raman R, Thomas RG, Yurko-Mauro K, Nelson EB, Van Dyck C, et al. Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial. JAMA 2010;304(17):1903–11.
   PubMed Web of Science ®Google Scholar
• Whalley LJ, Deary IJ, Starr JM, Wahle KW, Rance KA, Bourne VJ, et al. n-3 fatty acid erythrocyte membrane content, APOE varepsilon4, and cognitive variation: an observational follow-up study in late adulthood. Am J Clin Nutr 2008;87(2):449–54.
   PubMed Web of Science ®Google Scholar
• Morris MC, Brockman J, Schneider JA, Wang Y, Bennett DA, Tangney CC, et al. Association of seafood consumption, brain mercury level, andAPOE ϵ4Status with brain neuropathology in older adults. JAMA 2016;315(5):489–97.
   PubMed Web of Science ®Google Scholar
• Kröger E, Verreault R, Carmichael P-H, Lindsay J, Julien P, Dewailly É, et al. Omega-3 fatty acids and risk of dementia: the Canadian study of health and aging. Am J Clin Nutr 2009;90(1):184–92.
   PubMed Web of Science ®Google Scholar
• Erecińska M, Zaleska MM, Nissim I, Nelson D, Dagani F, Yudkoff M. Glucose and synaptosomal glutamate metabolism: studies with [15N]glutamate. J Neurochem 1988;51(3):892–902.
   PubMed Web of Science ®Google Scholar
• Lau A, Tymianski M. Glutamate receptors, neurotoxicity and neurodegeneration. Pflugers Arch – Eur J Physiol 2010;460(2):525–42.
   PubMed Web of Science ®Google Scholar
• Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 1977;74(12):5463–7.
   PubMed Web of Science ®Google Scholar
• Croft JB, Keenan NL, Sheridan DP, Wheeler FC, Speers MA. Waist-to-hip ratio in a biracial population: measurement, implications, and cautions for using guidelines to define high risk for cardiovascular disease. J Am Diet Assoc 1995;95(1):60–4.
   PubMed Web of Science ®Google Scholar
• Leech R, Sharp DJ. The role of the posterior cingulate cortex in cognition and disease. Brain J Neurol 2014;137(1):12–32.
   Google Scholar
• Herholz K, Salmon E, Perani D, Baron J-C, Holthoff V, Frölich L, et al. Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET. Neuroimage 2002;17(1):302–16.
   PubMed Web of Science ®Google Scholar
• Kantarci K, Jack CR, Xu YC, Campeau NG, O'Brien PC, Smith GE, et al. Regional metabolic patterns in mild cognitive impairment and Alzheimer's disease: a 1H MRS study. Neurology 2000;55(2):210–7.
   PubMed Web of Science ®Google Scholar
• Provencher SW. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 1993;30(6):672–9.
   PubMed Web of Science ®Google Scholar
• Lezak MD. Neuropsychological assessment. New York: Oxford University Press; 1995.
   Google Scholar
• Delis DC, Kramer JH, Kaplan E, Ober BA. California verbal learning test: adult version. San Antonio: The Psychological Corporation; 1987.
   Google Scholar
• Reitan RM. Validity of the trail making test as an indicator of organic brain damage. Percept Mot Skills 1958;8:271–6.
   Google Scholar
• Wechsler D. WAIS-III administration and scoring manual. San Antonio: The Psychological Corporation; 1997.
   Google Scholar
• Eslinger P. The Iowa screening battery for mental decline. Iowa: University of Iowa College of Medicine; 1984.
   Google Scholar
• Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12(3):189–98.
   PubMed Web of Science ®Google Scholar
• Wechsler D. Weschler test of adult reading: WTAR. San Antonio: The Psychological Corporation; 2001.
   Google Scholar
• Hayes AF. Introduction to mediation, moderation, and conditional process analysis: a regression-based approach. 2018.
   Google Scholar
• Hughes ML, Agrigoroaei S, Jeon M, Bruzzese M, Lachman ME. Change in cognitive performance from midlife into old age: findings from the midlife in the United States (MIDUS) study. J Int Neuropsychol Soc 2018;24(8):1–16.
   PubMed Web of Science ®Google Scholar
• Kesse-Guyot E, Andreeva VA, Touvier M, Jeandel C, Ferry M, Hercberg S, et al. Overall and abdominal adiposity in midlife and subsequent cognitive function. J Nutr Health Aging 2015;19(2):183–9.
   PubMed Web of Science ®Google Scholar
• Kramer JH, Delis DC, Daniel M. Sex differences in verbal learning. J Clin Psychol 1988;44(6):907–15.
   Web of Science ®Google Scholar
• Bleecker ML, Bolla-Wilson K, Agnew J, Meyers DA. Age-related sex differences in verbal memory. J Clin Psychol 1988;44(3):403–11.
   PubMed Web of Science ®Google Scholar
• Willett W, Stampfer MJ. Total energy intake: implications for epidemiologic analyses. Am J Epidemiol 1986;124(1):17–27.
   PubMed Web of Science ®Google Scholar
• Klop B, Elte JWF, Castro Cabezas M. Dyslipidemia in obesity: mechanisms and potential targets. Nutrients 2013;5(4):1218–40.
   PubMed Web of Science ®Google Scholar
• Loef M, Walach H. The omega-6/omega-3 ratio and dementia or cognitive decline: a systematic review on human studies and biological evidence. (2155-1200 (Electronic)).
   Google Scholar
• Eskelinen MH, Ngandu T, Helkala E-L, Tuomilehto J, Nissinen A, Soininen H, et al. Fat intake at midlife and cognitive impairment later in life: a population-based CAIDE study. Int J Geriatr Psychiatry 2008;23(7):741–7.
   PubMed Web of Science ®Google Scholar
• Kalmijn S, van Boxtel MPJ, Ocke M, Verschuren WMM, Kromhout D, Launer LJ. Dietary intake of fatty acids and fish in relation to cognitive performance at middle age. Neurology 2004;62(2):275–80.
   PubMed Web of Science ®Google Scholar
• Yurko-Mauro K, Alexander DD, Van Elswyk ME, Reddy H. Docosahexaenoic acid and adult memory: a systematic review and meta-analysis. PLoS ONE 2015;10(3):e0120391.
   PubMedGoogle Scholar
• Sydenham E, Dangour AD, Lim WS. Omega 3 fatty acid for the prevention of cognitive decline and dementia. Cochrane Database Syst Rev 2012;13(6):419,CD005379.
   Google Scholar
• Yassine HN, Braskie MN, Mack WJ, Castor KJ, Fonteh AN, Schneider LS, et al. Association of docosahexaenoic acid supplementation with Alzheimer disease stage in apolipoprotein E ϵ4 carriers. JAMA Neurol 2017;74(3):339–47.
   PubMed Web of Science ®Google Scholar
• Dumanis SB, DiBattista AM, Miessau M, Moussa CEH, Rebeck GW. APOE genotype affects the presynaptic compartment of glutamatergic nerve terminals. J Neurochem 2013;124(1):4–14.
   PubMed Web of Science ®Google Scholar
• Kariv-Inbal Z, Yacobson S, Berkecz R, Peter M, Janaky T, Lutjohann D, et al. The isoform-specific pathological effects of apoE4 in vivo are prevented by a fish oil (DHA) diet and are modified by cholesterol. J Alzheimer's Dis 2012;28(3):667–83.
   PubMed Web of Science ®Google Scholar
• Daniels RW, Collins CA, Chen K, Gelfand MV, Featherstone DE, DiAntonio A. A single vesicular glutamate transporter is sufficient to fill a synaptic vesicle. Neuron 2006;49(1):11–6.
   PubMed Web of Science ®Google Scholar
• Chen Y, Durakoglugil MS, Xian X, Herz J. Apoe4 reduces glutamate receptor function and synaptic plasticity by selectively impairing ApoE receptor recycling. Proc Natl Acad Sci USA 2010;107(26):12011–6.
   PubMed Web of Science ®Google Scholar
• Lane RM, Farlow MR. Lipid homeostasis and apolipoprotein E in the development and progression of Alzheimer's disease. J Lipid Res 2005;46(5):949–68.
   PubMed Web of Science ®Google Scholar
• Kivipelto M, Rovio S, Ngandu T, Kåreholt I, Eskelinen M, Winblad B, et al. Apolipoprotein E ϵ4 magnifies lifestyle risks for dementia: a population-based study. J Cell Mol Med 2008;12(6b):2762–71.
   PubMed Web of Science ®Google Scholar
• Olano-Martin E, Anil E, Caslake MJ, Packard CJ, Bedford D, Stewart G, et al. Contribution of apolipoprotein E genotype and docosahexaenoic acid to the LDL-cholesterol response to fish oil. Atherosclerosis 2010;209(1):104–10.
   PubMed Web of Science ®Google Scholar
• Chouinard-Watkins R, Plourde M. Fatty acid metabolism in carriers of apolipoprotein E epsilon 4 allele: is it contributing to higher risk of cognitive decline and coronary heart disease? Nutrients 2014;6(10):4452–71.
   PubMed Web of Science ®Google Scholar
• Siscovick DS, Barringer TA, Fretts AM, Wu JHY, Lichtenstein AH, Costello RB, et al. Omega-3 polyunsaturated fatty acid (fish oil) supplementation and the prevention of clinical cardiovascular disease: a science advisory from the American Heart Association. Circulation. 2017.
   Google Scholar
• Jansen D, Zerbi V, Janssen CIF, van Rooij D, Zinnhardt B, Dederen PJ, et al. Impact of a multi-nutrient diet on cognition, brain metabolism, hemodynamics, and plasticity in apoE4 carrier and apoE knockout mice. Brain Struct Funct 2014;219(5):1841–68.
   PubMed Web of Science ®Google Scholar
• Thompson FE, Subar AF. Dietary assessment methodology. In: Coulston AM, Boushey CJ, (eds.) Nutrition in the prevention and treatment of disease. San Diego: Academic Press; 2008. p. 5–48.
   Google Scholar
• Palmisano BT, Zhu L, Eckel RH, Stafford JM. Sex differences in lipid and lipoprotein metabolism. Mol Metab 2018;15:45–55.
   PubMed Web of Science ®Google Scholar